Suppr超能文献

纤溶抑制和低纤溶不是同义词:区分低纤溶状态的临床意义。

Fibrinolysis Shutdown and Hypofibrinolysis Are Not Synonymous Terms: The Clinical Significance of Differentiating Low Fibrinolytic States.

机构信息

Division of Transplant Surgery, Department of Surgery, University of Colorado Denver, Aurora, Colorado.

出版信息

Semin Thromb Hemost. 2023 Jul;49(5):433-443. doi: 10.1055/s-0042-1758057. Epub 2022 Nov 1.

Abstract

Low fibrinolytic activity has been associated with pathologic thrombosis and multiple-organ failure. Low fibrinolytic activity has two commonly associated terms, hypofibrinolysis and fibrinolysis shutdown. Hypofibrinolysis is a chronic state of lack of ability to generate an appropriate fibrinolytic response when anticipated. Fibrinolysis shutdown is the shutdown of fibrinolysis after systemic activation of the fibrinolytic system. There has been interchanging of these terms to describe critically ill patients in multiple settings. This is problematic in understanding the pathophysiology of disease processes related to these conditions. There is also a lack of research on the cellular mediators of these processes. The purpose of this article is to review the on and off mechanisms of fibrinolysis in the context of low fibrinolytic states to define the importance in differentiating hypofibrinolysis from fibrinolysis shutdown. In many clinical scenarios, the etiology of a low fibrinolytic state cannot be determined due to ambiguity if a preceding fibrinolytic activation event occurred. In this scenario, the term "low fibrinolytic activity" or "fibrinolysis resistance" is a more appropriate descriptor, rather than using assumptive of hypofibrinolysis and fibrinolysis shutdown, particularly in the acute setting of infection, injury, and surgery.

摘要

纤溶活性降低与病理性血栓形成和多器官衰竭有关。纤溶活性降低有两个常见的相关术语,低纤溶和纤溶失活。低纤溶是指在预期情况下缺乏产生适当纤溶反应的能力的慢性状态。纤溶失活是指在全身激活纤溶系统后纤溶的失活。这些术语在多个环境中被用来描述危重症患者,这在理解与这些情况相关的疾病过程的病理生理学方面存在问题。这些过程的细胞介质的研究也很少。本文的目的是在低纤溶状态的背景下回顾纤溶的开启和关闭机制,以确定区分低纤溶和纤溶失活的重要性。在许多临床情况下,由于先前是否发生过纤溶激活事件的不明确性,无法确定低纤溶状态的病因。在这种情况下,“低纤溶活性”或“纤溶抵抗”是一个更合适的描述符,而不是假设低纤溶和纤溶失活,特别是在感染、损伤和手术的急性情况下。

相似文献

2
Fibrinolytic Shutdown Is Associated With Intraoperative Thrombosis and Hemorrhage During Visceral Transplant.
Semin Cardiothorac Vasc Anesth. 2019 Sep;23(3):300-308. doi: 10.1177/1089253219848441. Epub 2019 May 8.
3
Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications.
Anesth Analg. 2019 Sep;129(3):762-773. doi: 10.1213/ANE.0000000000004234.
4
Differentiating Pathologic from Physiologic Fibrinolysis: Not as Simple as Conventional Thrombelastography.
J Am Coll Surg. 2024 Jul 1;239(1):30-41. doi: 10.1097/XCS.0000000000001027. Epub 2024 Feb 1.
5
Temporal Changes in Fibrinolysis following Injury.
Semin Thromb Hemost. 2020 Mar;46(2):189-198. doi: 10.1055/s-0039-1701016. Epub 2020 Mar 11.
6
Analysis of fibrinolytic shutdown in trauma patients with traumatic brain injury.
Am J Surg. 2024 Jan;227:72-76. doi: 10.1016/j.amjsurg.2023.09.034. Epub 2023 Sep 26.
7
Persistent fibrinolysis shutdown is associated with increased mortality in traumatic pancreatic injury.
Injury. 2023 May;54(5):1265-1270. doi: 10.1016/j.injury.2023.02.013. Epub 2023 Feb 7.
8
Decreased Plasma Fibrinolytic Potential As a Risk for Venous and Arterial Thrombosis.
Semin Thromb Hemost. 2017 Mar;43(2):178-184. doi: 10.1055/s-0036-1585081. Epub 2016 Jul 29.
9
Elucidating the molecular mechanisms of fibrinolytic shutdown after severe injury: The role of thrombin-activatable fibrinolysis inhibitor.
J Trauma Acute Care Surg. 2023 Jun 1;94(6):857-862. doi: 10.1097/TA.0000000000003911. Epub 2023 Feb 13.

引用本文的文献

2
[Point of care coagulation diagnostics-Absolutely necessary or only a reasonable supplement?].
Anaesthesiologie. 2025 May;74(5):264-274. doi: 10.1007/s00101-025-01524-7. Epub 2025 Apr 2.
3
Anticoagulation in venovenous extracorporeal membrane oxygenation.
Front Med (Lausanne). 2025 Mar 4;12:1530411. doi: 10.3389/fmed.2025.1530411. eCollection 2025.
4
Fibrinolytic Changes in Critical Illnesses: Is Fibrinolysis Shutdown a Specific Concept?
Juntendo Iji Zasshi. 2024 Dec 31;70(6):416-419. doi: 10.14789/ejmj.JMJ24-0035-P. eCollection 2024.
5
Hemogram-Based Phenotypes of the Immune Response and Coagulopathy in Blunt Thoracic Trauma.
J Pers Med. 2024 Dec 21;14(12):1168. doi: 10.3390/jpm14121168.
6
Hyperfibrinolysis: a crucial phenotypic abnormality of posttraumatic fibrinolytic dysfunction.
Res Pract Thromb Haemost. 2024 Sep 11;8(7):102568. doi: 10.1016/j.rpth.2024.102568. eCollection 2024 Oct.
7
Connecting impaired fibrinolysis and dyslipidemia.
Res Pract Thromb Haemost. 2024 Apr 5;8(3):102394. doi: 10.1016/j.rpth.2024.102394. eCollection 2024 Mar.
8
COVID-19: Not a thrombotic disease but a thromboinflammatory disease.
Ups J Med Sci. 2024 Jan 22;129. doi: 10.48101/ujms.v129.9863. eCollection 2024.
9
Maintaining the balance: the critical role of plasmin activity in orthopedic surgery injury response.
J Thromb Haemost. 2023 Oct;21(10):2653-2665. doi: 10.1016/j.jtha.2023.08.002. Epub 2023 Aug 8.

本文引用的文献

1
Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
J Am Coll Cardiol. 2022 Aug 9;80(6):565-578. doi: 10.1016/j.jacc.2022.05.033.
2
The Plasminogen-Activator Plasmin System in Physiological and Pathophysiological Angiogenesis.
Int J Mol Sci. 2021 Dec 29;23(1):337. doi: 10.3390/ijms23010337.
4
A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease.
Front Cardiovasc Med. 2021 Apr 16;8:653655. doi: 10.3389/fcvm.2021.653655. eCollection 2021.
5
Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.
J Am Coll Surg. 2021 Jun;232(6):995-1003. doi: 10.1016/j.jamcollsurg.2021.02.019. Epub 2021 Mar 22.
6
Endothelial inflammatory and thrombogenic expression changes in microvascular anastomoses - An immunohistochemical analysis.
J Craniomaxillofac Surg. 2021 May;49(5):422-429. doi: 10.1016/j.jcms.2021.02.006. Epub 2021 Feb 12.
7
The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective.
Int J Mol Sci. 2021 Jan 28;22(3):1283. doi: 10.3390/ijms22031283.
8
The role of cell-free DNA in fibrinolysis for intraventricular hemorrhage.
J Neurosurg. 2021 Jan 8;135(4):1105-1112. doi: 10.3171/2020.7.JNS201429. Print 2021 Oct 1.
9
Flow-mediated vasodilation through mechanosensitive G protein-coupled receptors in endothelial cells.
Trends Cardiovasc Med. 2022 Feb;32(2):61-70. doi: 10.1016/j.tcm.2020.12.010. Epub 2021 Jan 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验